Author:
Sullivan W.,Hirst M.,Beard S.,Gladwell D.,Fagnani F.,López Bastida J.,Phillips C.,Dunlop W. C. N.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference30 articles.
1. Merskey, H., Bogduk, N: Classification of chronic pain. IASP task force on taxonomy. International Association for the Study of Pain Press, Seattle, WA (1994). http://www.iasp-pain.org
2. Merchant, S., et al.: Budget impact analysis of tapentadol extended release for the treatment of moderate to severe chronic noncancer pain. Clin. Ther. 35(5), 659–672 (2013)
3. World Health Organization: WHO’s cancer pain ladder for adults. http://www.who.int/cancer/palliative/painladder/en/ (2014). Accessed 10 Sept 2014
4. Breivik, H., Eisenberg, E., Tony, O.: The individual and societal burden of chronic pain in Europe: the case for strategic prioritisation and action to improve knowledge and availability of appropriate care. BMC public health 13(1), 1229 (2013)
5. Neil, N., et al.: Clinical simulation model of long-acting opioids for treatment of chronic non-cancer pain in the United States. J. Med. Econ. 16(2), 307–317 (2013)